Live Quote · NASDAQNMRAHealthcare· Biotechnology

Neumora Therapeutics, Inc. Common Stock

$0.33▼ 3.78%($-0.01)
MKT CAP $63.01MNEXT EARNINGS Mar 29, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
90
Valuation
20
Profitability
40
Growth
72
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NMRA research report →

Analyst Price Target
$4.50+1247.7% vs. today

Range $4 – $5

Analyst RatingBuy
6 Buy1 Hold2 Sell

Price Chart

-85.85% · this period
$3.59$1.96$0.33Nov 20May 26Nov 20
52-Week Range1% of range
Low
$0.30
Current
$0.33
High
$3.65